Clinical Trials Directory

Trials / Completed

CompletedNCT04716920

Tai Chi for Relieving Aromatase Inhibitor-Induced Arthralgia in Patients With Stage I-III Breast Cancer, the TaiChi4Joint Trial

Tai Chi for Relieving Aromatase Inhibitor-Induced Arthralgia in Breast Cancer Patients

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
39 (actual)
Sponsor
Thomas Jefferson University · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

This trial studies new methods using Tai Chi for the relief of joint pain (arthralgia) caused by an aromatase inhibitor in patients with stage I-III breast cancer. Tai Chi is a mind-body therapy that integrates moderate physical activity, deep breathing and meditation. Tai Chi may help to reduce aromatase inhibitor-induced joint pain, and offer a promising approach to managing symptoms in cancer patients.

Detailed description

PRIMARY OBJECTIVE: I. To evaluate the feasibility, acceptability, and preliminary efficacy of a 12-week Tai Chi intervention for relieving aromatase inhibitor (AI)-induced arthralgia in women with breast cancer (BCa). OUTLINE: Patients attend Tai Chi exercise classes over 1 hour twice weekly (BIW) and wear a Fitbit device for up to 12 weeks. Patients are encouraged to complete self-practice over 30 minutes and record practice times daily in a diary log form. Patients also join a Facebook private TaiChi4joint group where they receive instructional videos matching the progress of weekly classes for at-home practices and peer support in Tai Chi engagement.

Conditions

Interventions

TypeNameDescription
OTHERTai ChiAttend Tai Chi exercise classes
DEVICEFitBitWear FitBit
OTHERSupport Group TherapyJoin Tai4Chijoint group
OTHERQuestionnaire AdministrationAncillary studies
OTHERQuality-of-Life AssessmentAncillary studies

Timeline

Start date
2020-03-11
Primary completion
2021-07-21
Completion
2021-12-23
First posted
2021-01-20
Last updated
2025-04-29

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04716920. Inclusion in this directory is not an endorsement.